Variant report
Variant | nsv1052224 |
---|---|
Chromosome Location | chr13:89678943-89727015 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550266365 | chr13:89681025-89681026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368435650 | chr13:89681033-89681034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564964733 | chr13:89681071-89681072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535886987 | chr13:89681092-89681093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145217904 | chr13:89681097-89681098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566623550 | chr13:89681114-89681115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575255785 | chr13:89681141-89681142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534107849 | chr13:89681165-89681166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544262645 | chr13:89681166-89681167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186096755 | chr13:89681167-89681168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190766403 | chr13:89681206-89681207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183423036 | chr13:89681244-89681245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186190699 | chr13:89681260-89681261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10444609 | chr13:89681270-89681271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190602254 | chr13:89681278-89681279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575692166 | chr13:89681289-89681290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543072109 | chr13:89681292-89681293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561357004 | chr13:89681293-89681294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549884104 | chr13:89681295-89681296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555035531 | chr13:89681351-89681352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182952223 | chr13:89681483-89681484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540931183 | chr13:89681484-89681485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371870023 | chr13:89681520-89681521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375496805 | chr13:89681570-89681571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188227658 | chr13:89681584-89681585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550253939 | chr13:89681602-89681603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562279815 | chr13:89681605-89681606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529759182 | chr13:89681618-89681619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547840941 | chr13:89681681-89681682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566469572 | chr13:89681749-89681750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2348216 | chr13:89681782-89681783 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs552491464 | chr13:89681816-89681817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372637760 | chr13:89681817-89681818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148743604 | chr13:89681833-89681834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557467419 | chr13:89681855-89681856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575781055 | chr13:89681904-89681905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551375658 | chr13:89681936-89681937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142301488 | chr13:89681940-89681941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112239384 | chr13:89681977-89681978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192925089 | chr13:89682014-89682015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182997419 | chr13:89682057-89682058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540569977 | chr13:89682063-89682064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188036517 | chr13:89682110-89682111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577009031 | chr13:89682111-89682112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146819545 | chr13:89682165-89682166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191373152 | chr13:89682225-89682226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34390272 | chr13:89682264-89682265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375717003 | chr13:89682294-89682295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374047155 | chr13:89682307-89682308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562756152 | chr13:89682317-89682318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:89681000-89681800 | Enhancers | Dnd41 | blood |
2 | chr13:89681800-89682800 | Weak transcription | Dnd41 | blood |
3 | chr13:89682800-89683000 | Enhancers | Dnd41 | blood |
4 | chr13:89708600-89709000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr13:89709000-89709400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr13:89709000-89709400 | Enhancers | Brain Cingulate Gyrus | brain |
7 | chr13:89709200-89709400 | Enhancers | Brain Hippocampus Middle | brain |
8 | chr13:89709400-89710600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr13:89709400-89710600 | Weak transcription | Brain Hippocampus Middle | brain |
10 | chr13:89710600-89711600 | Enhancers | Brain Hippocampus Middle | brain |
11 | chr13:89714200-89714600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr13:89714200-89714600 | Enhancers | Gastric | stomach |
13 | chr13:89714200-89714600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
14 | chr13:89714200-89714800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr13:89714400-89714800 | Enhancers | HepG2 | liver |
16 | chr13:89714600-89719400 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
17 | chr13:89719000-89719400 | Enhancers | Primary hematopoietic stem cells | blood |
18 | chr13:89719000-89719400 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr13:89719200-89719600 | Enhancers | Fetal Kidney | kidney |
20 | chr13:89719400-89719600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr13:89719400-89719600 | Enhancers | Fetal Lung | lung |
22 | chr13:89719400-89719800 | Enhancers | Rectal Mucosa Donor 31 | rectum |